ROME, Italy—Mauna Kea Technologies, an endomicroscopy company, this week announced highlights of the Fourth Annual International Conference of Cellvizio® Users (ICCU), which took place late last month in Rome.
Co-chairs included: Bertrand Napoléon, MD, a specialist in gastroenterology at Jean Mermoz Private Hospital in Lyon, France; Kenneth Chang, MD, professor and chief, Division of Gastroenterology and executive director of the H.H. Chao Comprehensive Digestive Disease Center at the University of California, Irvine School of Medicine.
The co-chairs designed the program, which included more than 29 abstracts, posters and case studies presented by leaders in endoscopy from 14 countries on the use of Cellvizio as an advanced imaging tool across specialties. Topics included outcomes and best practices associated with using Cellvizio as a tool to help improve the diagnosis, treatment and management of patients with digestive and respiratory diseases, as well as, new areas of clinical investigation, including urology, intensive care and robotic surgery. More than 120 international experts in endoscopy, representing numerous fields in medicine, attended the three-day conference.
"This year's ICCU provided a robust educational and information-sharing forum on indications associated with endomicroscopy as well as areas currently under research," Dr. Napoléon said. "The exchange amongst users from different countries facilitated a broad understanding of how Cellvizio helps physicians more accurately characterize disease and take more informed and efficient treatment decisions for patients. Seeing the enthusiasm of our American colleagues and the strong potential behind the technology, we feel that we are entering a new era in endoscopy. This is similar to what we experienced with echoendoscopy over 20 years ago."
